Federal RuleAug 21
62
DOL Rewrites Disability Rules for 'Merit-Based Opportunity' Push
RuleLabor DepartmentFederal Contract Compliance Programs OfficeSignificant Wallet
117-hr-6973117th Congress
Enhanced Access to Affordable Medicines Act of 2022
Sponsored By: Representative Carter, Earl L. "Buddy" [R-GA-1]
Unknown
Summary
Enhanced Access to Affordable Medicines Act of 2022 This bill specifies that the Food and Drug Administration may approve generic drugs with different labels than the brand-name versions if, among other requirements, the brand-name drug is subject to an active patent or exclusivity period and a revised label for the brand-name drug is approved within 90 days (rather than 60 days) of the expiration of the patent or exclusivity period.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
Carter, Earl L. "Buddy" [R-GA-1]
GA • R
Cosponsors
Rep. Craig, Angie [D-MN-2]
MN • D
Sponsored 4/26/2022
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov